244 related articles for article (PubMed ID: 16647629)
41. Function and regulation of epithelial sodium transporters in the kidney of a salt-sensitive hypertensive rat model.
Li J; Wang DH
J Hypertens; 2007 May; 25(5):1065-72. PubMed ID: 17414671
[TBL] [Abstract][Full Text] [Related]
42. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats.
Guo Q; Mori T; Jiang Y; Hu C; Osaki Y; Yoneki Y; Sun Y; Hosoya T; Kawamata A; Ogawa S; Nakayama M; Miyata T; Ito S
J Hypertens; 2009 Aug; 27(8):1664-71. PubMed ID: 19531965
[TBL] [Abstract][Full Text] [Related]
43. Oxidative stress contributes to renovascular hypertension.
Oliveira-Sales EB; Dugaich AP; Carillo BA; Abreu NP; Boim MA; Martins PJ; D'Almeida V; Dolnikoff MS; Bergamaschi CT; Campos RR
Am J Hypertens; 2008 Jan; 21(1):98-104. PubMed ID: 18091751
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.
Durand MJ; Raffai G; Weinberg BD; Lombard JH
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1024-33. PubMed ID: 20656887
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II receptor activation in youth triggers persistent insulin resistance and hypertension--a legacy effect?
Togashi N; Maeda T; Yoshida H; Koyama M; Tanaka M; Furuhashi M; Shimamoto K; Miura T
Hypertens Res; 2012 Mar; 35(3):334-40. PubMed ID: 22129514
[TBL] [Abstract][Full Text] [Related]
46. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy.
Tomohiro T; Kumai T; Sato T; Takeba Y; Kobayashi S; Kimura K
Life Sci; 2007 Mar; 80(15):1364-72. PubMed ID: 17331548
[TBL] [Abstract][Full Text] [Related]
47. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
[TBL] [Abstract][Full Text] [Related]
48. [Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II].
Delbosc S; Cristol JP; Mimran A; Jover B
Arch Mal Coeur Vaiss; 2001 Nov; 94(11):1199-202. PubMed ID: 11794990
[TBL] [Abstract][Full Text] [Related]
49. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats.
Alvarez Y; Pérez-Girón JV; Hernanz R; Briones AM; García-Redondo A; Beltrán A; Alonso MJ; Salaices M
J Pharmacol Exp Ther; 2007 Apr; 321(1):381-8. PubMed ID: 17244722
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.
Majid DS; Kopkan L
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):946-52. PubMed ID: 17645645
[TBL] [Abstract][Full Text] [Related]
51. Mineralocorticoid pretreatment enhances angiotensin II-induced neuronal excitation but not salt drinking in male Fischer rats.
Omouessi ST; Falconetti C; Chapleur M; Fernette B; Thornton SN
J Neuroendocrinol; 2007 Feb; 19(2):109-15. PubMed ID: 17214873
[TBL] [Abstract][Full Text] [Related]
52. Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats.
Collister JP; Nahey DB
J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):10-6. PubMed ID: 18404603
[TBL] [Abstract][Full Text] [Related]
53. AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension.
Lara LS; McCormack M; Semprum-Prieto LC; Shenouda S; Majid DS; Kobori H; Navar LG; Prieto MC
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F85-94. PubMed ID: 21900456
[TBL] [Abstract][Full Text] [Related]
54. Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart.
Chen Y; Currie RW
Inflamm Res; 2005 Aug; 54(8):338-43. PubMed ID: 16158334
[TBL] [Abstract][Full Text] [Related]
55. Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet.
Drenjancevic-Peric I; Lombard JH
Hypertension; 2005 Apr; 45(4):687-91. PubMed ID: 15710779
[TBL] [Abstract][Full Text] [Related]
56. Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension.
Long DA; Mu W; Price KL; Roncal C; Schreiner GF; Woolf AS; Johnson RJ
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1248-54. PubMed ID: 16804104
[TBL] [Abstract][Full Text] [Related]
57. Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat.
King AJ; Novotny M; Swain GM; Fink GD
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1262-7. PubMed ID: 18256139
[TBL] [Abstract][Full Text] [Related]
58. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system.
Zimmerman MC; Lazartigues E; Sharma RV; Davisson RL
Circ Res; 2004 Jul; 95(2):210-6. PubMed ID: 15192025
[TBL] [Abstract][Full Text] [Related]
59. Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats.
Petcu M; Ongali B; El Midaoui A; de Champlain J; Couture R
Peptides; 2005 Aug; 26(8):1331-8. PubMed ID: 15878793
[TBL] [Abstract][Full Text] [Related]
60. AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats.
Beyer AM; Fredrich K; Lombard JH
Am J Hypertens; 2013 Dec; 26(12):1398-404. PubMed ID: 23934707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
